1. Home
  2. SNY vs NWPX Comparison

SNY vs NWPX Comparison

Compare SNY & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • NWPX
  • Stock Information
  • Founded
  • SNY 1994
  • NWPX 1966
  • Country
  • SNY France
  • NWPX United States
  • Employees
  • SNY N/A
  • NWPX N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • NWPX Steel/Iron Ore
  • Sector
  • SNY Health Care
  • NWPX Industrials
  • Exchange
  • SNY Nasdaq
  • NWPX Nasdaq
  • Market Cap
  • SNY 116.5B
  • NWPX 416.3M
  • IPO Year
  • SNY N/A
  • NWPX 1995
  • Fundamental
  • Price
  • SNY $48.12
  • NWPX $41.50
  • Analyst Decision
  • SNY Buy
  • NWPX Hold
  • Analyst Count
  • SNY 2
  • NWPX 1
  • Target Price
  • SNY $62.50
  • NWPX $55.00
  • AVG Volume (30 Days)
  • SNY 2.1M
  • NWPX 64.6K
  • Earning Date
  • SNY 07-31-2025
  • NWPX 07-30-2025
  • Dividend Yield
  • SNY 3.32%
  • NWPX N/A
  • EPS Growth
  • SNY 39.56
  • NWPX 37.25
  • EPS
  • SNY 5.45
  • NWPX 3.27
  • Revenue
  • SNY $48,817,552,946.00
  • NWPX $495,448,000.00
  • Revenue This Year
  • SNY $3.39
  • NWPX $1.41
  • Revenue Next Year
  • SNY $7.05
  • NWPX $6.07
  • P/E Ratio
  • SNY $8.83
  • NWPX $12.95
  • Revenue Growth
  • SNY N/A
  • NWPX 8.06
  • 52 Week Low
  • SNY $45.80
  • NWPX $35.37
  • 52 Week High
  • SNY $60.12
  • NWPX $57.76
  • Technical
  • Relative Strength Index (RSI)
  • SNY 43.15
  • NWPX 53.39
  • Support Level
  • SNY $48.39
  • NWPX $41.68
  • Resistance Level
  • SNY $48.80
  • NWPX $43.34
  • Average True Range (ATR)
  • SNY 0.58
  • NWPX 1.12
  • MACD
  • SNY 0.11
  • NWPX 0.05
  • Stochastic Oscillator
  • SNY 29.95
  • NWPX 49.64

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About NWPX Northwest Pipe Company

NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.

Share on Social Networks: